The recent acquisitions by pharmaceutical giants Johnson & Johnson and Bristol Myers Squibb, worth a combined $28billion, highlight the growing interest in mental health treatment.Read More
You might also be interested in reading Lument Finance Trust outlines cautious optimism for 2025 lending activity.